Summary
84 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 19% a year over the last 3 years.
- Out of every 100 GBP of revenue, 16 GBP is left as net profit.
- It earns 19 GBP a year on every 100 GBP of invested capital.
- It holds more cash than debt: £14.9M against £5.82M.
What to watch
- 84% of profit goes to the dividend, leaving little room to raise it.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 24.6 GBP for 1 GBP of yearly profit. Over the last five years it was 33.6 GBP on average.
Valuation in detailIs it growing?
Yes, fastRevenue (GBP)
Diluted EPS (GBP)
- Analyst estimate
Revenue grew by 10% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 12%. Earnings per share grew by 19% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 GBP of revenue goes
- Cost of sales 23 GBP
- Sales and administration 55 GBP
- Taxes and other 5.9 GBP
- Net profit 16 GBP
Net profit, industry median (Medical - Instruments & Supplies) 8.2 GBP
Out of every 100 GBP of revenue, 16 GBP is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.41%
- Paid out of profit
- 84%
- Raised in a row
- 2 years
You receive $0.19 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.